🙏

So very honoured to be working with Dr. Antel on this potentially life changing drug development!

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit globenewswire.com/news-release/2…

x.com/i/spaces/1mrGm…

x.com/i/spaces/1mrGm…

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend globenewswire.com/news-release/2… #QNTM $QNTM

This can be potentially great news for $QNTM as these are the main prime brokers and market makers we have filed a complaint against. 🤞🤞🤞

Great work Jon!

CTV National News Inside Quantum BioPharma’s $700M Spoofing Case and MS Research Efforts Live On-Air recording by CTV News (CTV News) W5 investigative journalist Jon Woodward (Jon Woodward) exploring whether a Canadian company’s Multiple Sclerosis research was nearly derailed by

CTV News Tik Tok Coverage on Quantum Biopharma $QNTM talking about MS and Spoofing allegations. vt.tiktok.com/ZSfmFYsFH/

Thanks CTV News & W5's Investigative Journalism for taking the time to cover Quantum BioPharma’s story and for digging deeply into the alleged market-manipulation issues. $QNTM ‘Market manipulation’ cases trending up in Canada: regulator data. W5's Jon Woodward (Jon Woodward)

Quantum Biopharma $QNTM Coverage by CTV News W5’s Jon Woodward Jon Woodward. Investor Randy Manzardo & Terry Lynch Terry Lynch talk about market manipulation and spoofing. vt.tiktok.com/ZSfHUFKsT #Nasdaq #NYSE #biotech #marketmanipulation #spoofing

Breakthroughs in MS don’t happen by accident — they happen when someone finally looks at the biology differently. Most treatments in MS still revolve around the autoimmune narrative. But the science is shifting. Demyelination has a biochemical signature: citrullination. When

The letter (below) to SEC from $QNTM is requesting Chairman Paul Atkins to reconsider his decision to delay the Short Disclosure Transparency Rule that was supposed to go into effect in February of 2026. We would like to encourage other CEOs and anyone who is in this fight

Hey Rep. Tim Burchett Press Office Rep. Anna Paulina Luna , if you wanna stop Insider trading, use a different bill called "No Naked Shorting" 👈🏾😎 Watch who blocks it👀 Also investigate U.S. Securities and Exchange Commission FINRA Hester Peirce Paul Atkins for Securities Fraud. Shout out to Zeeshan Saeed 💯 #ApesNotLeaving

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares globenewswire.com/news-release/2… $QNTM #Nasdaq

G Ann Vandersteel™️ Thanks Ham! 🫡

I’m going to Kevin Malone’s upcoming Space. Will you join too? x.com/i/spaces/1OyKA…

PR - Quantum BioPharma completes Toxicity studies for Lucid MS $QNTM This is another step towards filing the IND (Investigational New Drug) application with the United States FDA to conduct a phase-2 clinical trial for Lucid MS. The plan is to file this application in the first

At Quantum BioPharma, we’re advancing science with the goal of improving outcomes for people living with multiple sclerosis. Learn more about Lucid-MS: quantumbiopharma.com/lucid-ms $QNTM #Biotech #Nasdaq #Multiplesclerosis